PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-202.45%
Both yoy net incomes decline, with TSM at -0.90%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-1.22%
Negative yoy D&A while TSM is 9.44%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-305.88%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-2.17%
Negative yoy SBC while TSM is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
156.04%
Well above TSM's 78.28% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
186.33%
AR growth of 186.33% while TSM is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
19.10%
Inventory shrinking or stable vs. TSM's 107.81%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-601.18%
Negative yoy AP while TSM is 59.42%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
444.25%
Some yoy usage while TSM is negative at -95.14%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
98.38%
Lower 'other non-cash' growth vs. TSM's 549.67%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
736.35%
Operating cash flow growth above 1.5x TSM's 11.66%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-120.40%
Negative yoy CapEx while TSM is 20.57%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-132.93%
Both yoy lines negative, with TSM at -51.31%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
140.35%
At 50-75% of TSM's 253.93%. Martin Whitman questions partial disadvantage if competitor monetizes investments more efficiently.
No Data
No Data available this quarter, please select a different quarter.
-107.70%
We reduce yoy invests while TSM stands at 50.43%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-3.55%
Both yoy lines negative, with TSM at -3082.00%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-76.55%
Negative yoy issuance while TSM is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.